Company Filing History:
Years Active: 1998
Title: Marie Marchand: Innovator in Lung Cancer Research
Introduction
Marie Marchand is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of cancer research, particularly in the area of lung adenocarcinomas. Her innovative methods have the potential to improve diagnostic techniques and patient outcomes.
Latest Patents
Marie Marchand holds a patent for a method that determines lung adenocarcinomas by assaying for the expression of genes coding for tumor rejection antigen precursors MAGE-1, 2, and 3, or their expression products. This patent represents a crucial advancement in the early detection of lung cancer.
Career Highlights
Marie is affiliated with the Ludwig Institute for Cancer Research Limited, where she continues her groundbreaking work. Her research focuses on developing methods that enhance the understanding and treatment of lung cancer.
Collaborations
Some of her notable coworkers include Thierry R Boon-Falleur and Patrick Weynants. Their collaborative efforts contribute to the advancement of cancer research and the development of innovative diagnostic methods.
Conclusion
Marie Marchand's work exemplifies the impact of innovation in medical research, particularly in the fight against lung cancer. Her contributions are paving the way for improved diagnostic techniques and better patient care.